The complaint centers on allegations that Peabody provided overly optimistic guidance regarding the ramp-up schedule at its Centurion facility. While the company touted specific production rates for fiscal year 2026, the lawsuit contends these projections failed to account for operational hurdles that ultimately delayed the project. The discrepancy became public on March 30, 2026, when a regulatory filing revealed a downward revision in output projections, causing Peabody stock to drop nearly 10% in a single day.
Further pressure mounted on May 5, 2026, when the company officially confirmed it had missed its March deadline for the Centurion ramp-up. This announcement resulted in another 5.7% decline in share value as the firm slashed its full-year volume guidance. Investors seeking to serve as lead plaintiff in the ongoing action have until August 24, 2026, to file their papers with the court. Robbins LLP is handling the case on a contingency fee basis, meaning participating shareholders incur no direct legal costs.


Comments (0)
No comments yet. Be the first!